CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
REVENUES	$ 114,802	$ 81,875
Cost of product revenue	53,705	42,767
Gross profit	61,097	39,108
OPERATING EXPENSES:
Research and development	826	450
Plasma center operating expenses	1,286	1,005
Amortization of intangible assets	25	193
Selling, general and administrative	24,079	15,639
Total operating expenses	26,216	17,287
INCOME FROM OPERATIONS	34,881	21,821
OTHER INCOME (EXPENSE):
Interest income	608	384
Interest expense	(1,975)	(3,769)
Other expense	(64)	(35)
Other expense, net	(1,431)	(3,420)
INCOME BEFORE INCOME TAXES	33,450	18,401
Provision for income taxes	6,546	595
NET INCOME	$ 26,904	$ 17,806
BASIC EARNINGS PER COMMON SHARE (in Dollars per share)	$ 0.11	$ 0.08
DILUTED EARNINGS PER COMMON SHARE (in Dollars per share)	$ 0.11	$ 0.08
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING:
Basic (in Shares)	237,775,476	228,874,847
Diluted (in Shares)	244,676,350	236,414,374